Sivakumar Vijayaraghavalu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sivakumar Vijayaraghavalu has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Borish Loushambam
Department of Life Sciences (Zoology), Manipur University (A Central University), Imphal 795003, MN, India
3 shared publications - Sorokhaibam Mexico Singh
Department of Life Sciences (Zoology), Manipur University, Imphal 795003, Manipur, India
2 shared publications - Yanglem Sangeeta
Department of Life Sciences (Botany), Manipur University, Indo-Myanmar Road, Canchipur 795 003, Manipur, India
2 shared publications - Mirinrinchuiphy M. K. Shimray
Department of Medical Science & Technology, Indian Institute of Technology Madras, Chennai 600036, TN, India
1 shared publication - Venkateshwaran Krishnaswami
Department of Pharmaceutics, S. A. Raja Pharmacy College, Tirunelveli, India
1 shared publication
Latest Publications
- Open Access
- 15 October 2026
- Published by MDPI AG in Journal of Pharmaceutical and BioTech Industry
- Vol. 3 (4) , 25
Engineering Protein Stability in Dissolving Microneedle Patches: Mechanistic Principles, Polymer Engineering, Formulation Strategies, and Clinical Translation for Insulin and Other Biologics
Protein therapeutics such as insulin, monoclonal antibodies, peptide hormones, cytokines, enzymes and vaccine antigens have revolutionized the treatment of chronic and complex diseases, but are currently constrained by adherence issues with frequent injection, cold-chain requirements and their intrinsic vulnerability to structural degradation. Dissolving microneedle (DMN) patches have recently been identified as a transdermal platform which allows minimally invasive, self-administered drug delivery and solid-state stabilization of fragile biologics. However, it is a significant challenge to keep the structural integrity and biological activity of proteins when developing the formulation, fabricating the microneedles, drying, storing the fabricates, and applying them to the skin. The mechanisms of molecular degradation (e.g., unfolding, aggregation, fibrillation, oxidation, deamidation, interface-induced denaturation) and stabilization (e.g., water replacement, vitrification, preferential hydration, and molecular confinement) all contribute to the stability of proteins in DMN matrices. Other processes also modulate these processes, such as polymer–protein interactions, residual moisture, glass-transition behavior, molecular mobility and microenvironmental physicochemical conditions. The rational engineering of polymer matrices, excipients systems and processing conditions therefore is the key to preserving a higher-order protein structure while providing sufficient mechanical properties, quick dissolution, higher drug loading efficiency and reproducible intradermal delivery. In recent years, a wide range of multifunctional biomaterials, hybrid polymer architectures, carrier-free insulin formulations and stimuli-responsive matrices have significantly broadened the design space for insulin and other biologic formulations that enables their stabilization during ambient and accelerated storage. Moreover, recent developments in biophysical characterization, solid-state analytical methods and computational modeling have helped to gain insight into formulation–structure–function relationships, and accelerated the rational optimization of protein-loaded DMN systems. Yet, there are still many difficulties to overcome for long-term stability, scalable manufacturing, quality-by-design implementation, regulatory standardization and global deployment. By combining mechanistic protein biophysics, pharmaceutical formulation and translational manufacturing, a platform for robust, cold-chain independent dissolving microneedles with a wide range of clinical applications across next-generation biologic therapeutics can be built.
- 15 October 2026
- Published by MDPI AG in Journal of Pharmaceutical and BioTech Industry
- Vol. 3 (4) , 25
Open AccessEngineering Protein Stability in Dissolving Microneedle Patches: Mechanistic Principles, Polymer Engineering, Formulation Strategies, and Clinical Translation for Insulin and Other Biologics
Protein therapeutics such as insulin, monoclonal antibodies, peptide hormones, cytokines, enzymes and vaccine antigens have revolutionized the treatment of chronic and complex diseases, but are currently constrained by adherence issues with frequent injection, cold-chain requirements and their intrinsic vulnerability to structural degradation. Dissolving microneedle (DMN) patches have recently been identified as a transdermal platform which allows minimally invasive, self-administered drug delivery and solid-state stabilization of fragile biologics. However, it is a significant challenge to keep the structural integrity and biological activity of proteins when developing the formulation, fabricating the microneedles, drying, storing the fabricates, and applying them to the skin. The mechanisms of molecular degradation (e.g., unfolding, aggregation, fibrillation, oxidation, deamidation, interface-induced denaturation) and stabilization (e.g., water replacement, vitrification, preferential hydration, and molecular confinement) all contribute to the stability of proteins in DMN matrices. Other processes also modulate these processes, such as polymer–protein interactions, residual moisture, glass-transition behavior, molecular mobility and microenvironmental physicochemical conditions. The rational engineering of polymer matrices, excipients systems and processing conditions therefore is the key to preserving a higher-order protein structure while providing sufficient mechanical properties, quick dissolution, higher drug loading efficiency and reproducible intradermal delivery. In recent years, a wide range of multifunctional biomaterials, hybrid polymer architectures, carrier-free insulin formulations and stimuli-responsive matrices have significantly broadened the design space for insulin and other biologic formulations that enables their stabilization during ambient and accelerated storage. Moreover, recent developments in biophysical characterization, solid-state analytical methods and computational modeling have helped to gain insight into formulation–structure–function relationships, and accelerated the rational optimization of protein-loaded DMN systems. Yet, there are still many difficulties to overcome for long-term stability, scalable manufacturing, quality-by-design implementation, regulatory standardization and global deployment. By combining mechanistic protein biophysics, pharmaceutical formulation and translational manufacturing, a platform for robust, cold-chain independent dissolving microneedles with a wide range of clinical applications across next-generation biologic therapeutics can be built.
- Open Access
Endogenous Neurotoxicity: A Pathophysiological Consequence of Homeostatic Dysfunction
Neurotoxicity is generally thought to result from exogenous agents like environmental chemicals, drugs and biological toxins. However, increasing evidence suggests that many endogenous molecules that play a critical role in normal brain function can become neurotoxic when the regulatory mechanism involved in their production, metabolism, compartmentalization and clearance are disrupted. This shift underlies the basis of endogenous neurotoxicity. This review discusses the major endogenous sources of neurotoxicity: metabolic neurotoxins, dysfunctional neurotransmitters, protein aggregates and inflammatory mediators. These endogenous factors arise from different physiological pathways, but share common pathogenic mechanisms, all of which involve an underlying state of oxidative stress, mitochondrial dysfunction, impaired proteostasis, excitotoxic signalling, neurovascular dysfunction and maladaptive neuroglial responses. This is not a singular process but a network of interconnected processes, which work together to progressively diminish neuronal resilience and promote synaptic dysfunction and neurodegeneration. The review also underscores the critical role of astrocytes, microglia and other glial cells in the maintenance of neuronal homeostasis. By integrating diverse endogenous neurotoxic pathways within a unified homeostasis-centred framework, this review provides a broader perspective on the mechanisms linking metabolic disorders, aging and neurodegenerative diseases. This framework suggests that effective therapeutic strategies may require restoration of physiological regulatory networks rather than targeting individual neurotoxic molecules in isolation. A systems-level understanding of endogenous neurotoxicity may therefore facilitate the development of earlier biomarkers and more effective interventions aimed at preserving neuronal homeostasis and preventing progressive neurological dysfunction.
Open AccessEndogenous Neurotoxicity: A Pathophysiological Consequence of Homeostatic Dysfunction
Neurotoxicity is generally thought to result from exogenous agents like environmental chemicals, drugs and biological toxins. However, increasing evidence suggests that many endogenous molecules that play a critical role in normal brain function can become neurotoxic when the regulatory mechanism involved in their production, metabolism, compartmentalization and clearance are disrupted. This shift underlies the basis of endogenous neurotoxicity. This review discusses the major endogenous sources of neurotoxicity: metabolic neurotoxins, dysfunctional neurotransmitters, protein aggregates and inflammatory mediators. These endogenous factors arise from different physiological pathways, but share common pathogenic mechanisms, all of which involve an underlying state of oxidative stress, mitochondrial dysfunction, impaired proteostasis, excitotoxic signalling, neurovascular dysfunction and maladaptive neuroglial responses. This is not a singular process but a network of interconnected processes, which work together to progressively diminish neuronal resilience and promote synaptic dysfunction and neurodegeneration. The review also underscores the critical role of astrocytes, microglia and other glial cells in the maintenance of neuronal homeostasis. By integrating diverse endogenous neurotoxic pathways within a unified homeostasis-centred framework, this review provides a broader perspective on the mechanisms linking metabolic disorders, aging and neurodegenerative diseases. This framework suggests that effective therapeutic strategies may require restoration of physiological regulatory networks rather than targeting individual neurotoxic molecules in isolation. A systems-level understanding of endogenous neurotoxicity may therefore facilitate the development of earlier biomarkers and more effective interventions aimed at preserving neuronal homeostasis and preventing progressive neurological dysfunction.
- Open Access
- 9 July 2026
- Published by MDPI AG in Preprints.org
Endogenous Neurotoxicity: A Pathophysiological Consequence of Homeostatic Dysfunction
Neurotoxicity is generally thought to result from exogenous agents like environmental chemicals, drugs and biological toxins. However, increasing evidence suggests that many endogenous molecules that play a critical role in normal brain function can become neu-rotoxic when the regulatory mechanism involved in their production, metabolism, com-partmentalization and clearance are disrupted. This shift underlies the basis of endoge-nous neurotoxicity. This review discusses the major endogenous sources of neurotoxicity: metabolic neuro-toxins, dysfunctional neurotransmitters, protein aggregates and inflammatory mediators. These endogenous factors arise from different physiological pathways, but share common pathogenic mechanisms, all of which involve an underlying state of oxidative stress, mi-tochondrial dysfunction, impaired proteostasis, excitotoxic signalling, neurovascular dysfunction and maladaptive neuroglial responses. This is not a singular process but a network of interconnected processes, which work together to progressively diminish neu-ronal resilience and promote synaptic dysfunction and neurodegeneration. The review also underscores the critical role of astrocytes, microglia and other glial cells in the maintenance of neuronal homeostasis. By integrating diverse endogenous neurotoxic pathways within a unified homeosta-sis-centred framework, this review provides a broader perspective on the mechanisms linking metabolic disorders, aging and neurodegenerative diseases. This framework sug-gests that effective therapeutic strategies may require restoration of physiological regula-tory networks rather than targeting individual neurotoxic molecules in isolation. A sys-tems-level understanding of endogenous neurotoxicity may therefore facilitate the devel-opment of earlier biomarkers and more effective interventions aimed at preserving neu-ronal homeostasis and preventing progressive neurological dysfunction.
- 9 July 2026
- Published by MDPI AG in Preprints.org
Open AccessEndogenous Neurotoxicity: A Pathophysiological Consequence of Homeostatic Dysfunction
Neurotoxicity is generally thought to result from exogenous agents like environmental chemicals, drugs and biological toxins. However, increasing evidence suggests that many endogenous molecules that play a critical role in normal brain function can become neu-rotoxic when the regulatory mechanism involved in their production, metabolism, com-partmentalization and clearance are disrupted. This shift underlies the basis of endoge-nous neurotoxicity. This review discusses the major endogenous sources of neurotoxicity: metabolic neuro-toxins, dysfunctional neurotransmitters, protein aggregates and inflammatory mediators. These endogenous factors arise from different physiological pathways, but share common pathogenic mechanisms, all of which involve an underlying state of oxidative stress, mi-tochondrial dysfunction, impaired proteostasis, excitotoxic signalling, neurovascular dysfunction and maladaptive neuroglial responses. This is not a singular process but a network of interconnected processes, which work together to progressively diminish neu-ronal resilience and promote synaptic dysfunction and neurodegeneration. The review also underscores the critical role of astrocytes, microglia and other glial cells in the maintenance of neuronal homeostasis. By integrating diverse endogenous neurotoxic pathways within a unified homeosta-sis-centred framework, this review provides a broader perspective on the mechanisms linking metabolic disorders, aging and neurodegenerative diseases. This framework sug-gests that effective therapeutic strategies may require restoration of physiological regula-tory networks rather than targeting individual neurotoxic molecules in isolation. A sys-tems-level understanding of endogenous neurotoxicity may therefore facilitate the devel-opment of earlier biomarkers and more effective interventions aimed at preserving neu-ronal homeostasis and preventing progressive neurological dysfunction.